NEW YORK (Reuters Health) – A third dose of the mRNA COVID-19 vaccine from Pfizer/BioNTech improves protection against the novel coronavirus in solid-organ transplant recipients, a population particularly vulnerable to more severe COVID-19-related outcomes, according to new study findings. A…
Read More
Indian Panel Says Global Response Needed to Contain More Infectious Virus Variant
NEW DELHI (Reuters) – The coronavirus variant first identified in India is highly infectious and can be caught by people who have already had the disease or been only partially vaccinated, a panel of Indian government scientists said in a…
Read More
Peru Revises Pandemic Death Toll, Now Worst in the World Per Capita
LIMA (Reuters) – Peru on Monday almost tripled its official COVID-19 death toll to 180,764, following a government review, making it the country with the worst death rate per capita, according to Johns Hopkins University data. Peru has been among…
Read More
Virus Might Insert Genetic Fragments Into Patients’ Genetic Code
(Reuters) – A controversial new paper based on laboratory experiments suggests a possible explanation for why some COVID-19 survivors still test positive on viral RNA tests months later: Small fragments of genetic instructions from the coronavirus might get integrated into…
Read More
Ad Campaign Critical of Japan’s Coronavirus Response Makes Waves
TOKYO (Reuters) – A newspaper ad criticising the Japanese government’s response to the nation’s fourth pandemic wave was widely shared on social media on Tuesday as public concerns mount over COVID-19 and official plans to host the Olympics, now just…
Read More
Scientists Say India Government Ignored Warnings Amid Coronavirus Surge
NEW DELHI (Reuters) – A forum of scientific advisers set up by the government warned Indian officials in early March of a new and more contagious variant of the coronavirus taking hold in the country, five scientists who are part…
Read More
Low Interferon Levels Drive Weak Response to the Virus
(Reuters) – People who become critically ill with COVID-19 appear to have lower-than-average levels of interferons, and a new study helps explain why low interferon levels would matter. Researchers identified 65 genes that are triggered into action by interferons –…
Read More
How a WHO Push for Global Vaccines Needled Europe
BRUSSELS (Reuters) – Last April, at the start of the COVID-19 pandemic, European Commission President Ursula von der Leyen added Europe to a global effort to ensure equitable access to a vaccine, which she said would be deployed “to every…
Read More